Status:
COMPLETED
Effects of a Patient Portal Intervention to Address Diabetes Care Gaps
Lead Sponsor:
Vanderbilt University Medical Center
Collaborating Sponsors:
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the effect of a novel patient portal intervention on the number of patients with diabetes care gaps (e.g., no diabetes eye exam i the last 12 months). The inte...
Detailed Description
Participants will be recruited from 14 VUMC-affiliate adult primary care clinics located throughout Middle Tennessee. Patients will be randomized 1:1 to the intervention or usual care. 500 adult patie...
Eligibility Criteria
Inclusion
- Established patient with a participating primary care physician from a participating clinic
- Type 1 or 2 diabetes mellitus
- Able to read in English
- Age 18 to 75 years old
- Mobile device (smartphone or tablet) with internet access
- Active My Health at Vanderbilt (MHAV) account
Exclusion
- A medical condition that prevents use of a mobile device
- Pregnant or planning to become pregnant during the study period
- Severe difficulty seeing
- On dialysis
Key Trial Info
Start Date :
April 30 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 2 2024
Estimated Enrollment :
440 Patients enrolled
Trial Details
Trial ID
NCT04894903
Start Date
April 30 2022
End Date
March 2 2024
Last Update
April 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37212